HIF‑1 signaling pathway involving iNOS, COX‑2 and caspase‑9 mediates the neuroprotection provided by erythropoietin in the retina of chronic ocular hypertension rats

Gui,Dongmei; Li,Yanfeng; Chen,Xiaolong; Gao,Dianwen; Yang,Yang; Li,Xun

doi:10.3892/mmr.2014.2859

HIF‑1 signaling pathway involving iNOS, COX‑2 and caspase‑9 mediates the neuroprotection provided by erythropoietin in the retina of chronic ocular hypertension rats

Authors:
- Dongmei Gui
- Yanfeng Li
- Xiaolong Chen
- Dianwen Gao
- Yang Yang
- Xun Li
View Affiliations

Affiliations: Department of Ophthalmology, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, P.R. China, Department of Neurosurgery, The People's Hospital of Liaoning Province, Shenyang, Liaoning 110025, P.R. China
Published online on: November 4, 2014 https://doi.org/10.3892/mmr.2014.2859
Pages: 1490-1496

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

This study aimed to investigate the impacts of erythropoietin (EPO) on the electroretinogram b‑wave (ERG‑b), and on the mRNA and protein expression levels of hypoxia‑inducible factor‑1α (HIF‑1α), inducible nitric oxide synthase (iNOS), cyclooxygenase‑2 (COX‑2) and caspase‑9 in chronic ocular hypertension rats. Episcleral vein cauterization (EVC) was used to establish the chronic ocular hypertension rat model based on the intraocular pressure (IOP) value. ERG‑b and mRNA and protein expression levels of HIF‑1α, iNOS, COX‑2 and caspase‑9 in normal, EVC‑treated and EVC combined with EPO (EVC+EPO)‑treated rats were measured by electroretinography, RT‑PCR and western blotting, respectively. Moreover, the correlations of HIF‑1α with IOP, ERG‑b, iNOS, COX‑2 and caspase‑9 were evaluated. The mRNA and protein expression levels of HIF‑1α, iNOS, COX‑2 and caspase‑9 in EVC‑treated rats were increased significantly compared with normal rats. The peak expression levels of HIF‑1α, iNOS, COX‑2 and caspase‑9 were respectively obtained 7, 7, 7 and 14 days postoperatively. Compared with EVC‑treated rats, EPO administration weakened the mRNA and protein expression levels of HIF‑1α, iNOS, COX‑2 and caspase‑9. The mRNA expression level of HIF‑1α demonstrated a significant positive correlation with IOP and ERG‑b. HIF‑1α was positively correlated with iNOS, COX‑2 and caspase‑9 at the mRNA and protein levels. The protective effect of EPO on the retina of chronic ocular hypertension rats may be mediated by the HIF‑1 signaling pathway involving iNOS, COX‑2 and caspase‑9.

View Figures

View References

1	Vohra R, Tsai JC and Kolko M: The role of inflammation in the pathogenesis of glaucoma. Surv Ophthalmol. 58:311–320. 2013. View Article : Google Scholar : PubMed/NCBI
2	Nickells RW: Ganglion cell death in glaucoma: from mice to men. Vet Ophthalmol. 10(Suppl 1): 88–94. 2007. View Article : Google Scholar : PubMed/NCBI
3	Semenza GL: HIF-1 and mechanisms of hypoxia sensing. Curr Opin Cell Biol. 13:167–171. 2001. View Article : Google Scholar : PubMed/NCBI
4	Tezel G and Wax MB: Hypoxia-inducible factor 1 alpha in the glaucomatous retina and optic nerve head. Arch Ophthalmol. 122:1348–1356. 2004. View Article : Google Scholar : PubMed/NCBI
5	Jiang B-H, Semenza GL, Bauer C and Marti HH: Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension. Am J Physiol. 271:C1172–C1180. 1996.PubMed/NCBI
6	Ergorul C, Ray A, Huang W, et al: Hypoxia inducible factor-1α (HIF-1α) and some HIF-1 target genes are elevated in experimental glaucoma. J Mol Neurosci. 42:183–191. 2010. View Article : Google Scholar : PubMed/NCBI
7	Zhu Y, Zhang L and Gidday JM: Role of hypoxia-inducible factor-1alpha in preconditioning-induced protection of retinal ganglion cells in glaucoma. Mol Vis. 19:2360–2372. 2013.
8	Whitlock NA, Agarwal N, Ma J-X and Crosson CE: Hsp27 upregulation by HIF-1 signaling offers protection against retinal ischemia in rats. Invest Ophthalmol Vis Sci. 46:1092–1098. 2005. View Article : Google Scholar : PubMed/NCBI
9	Gui DM, Yang Y, Li X and Gao DW: Effect of erythropoietin on the expression of HIF-1 and iNOS in retina in chronic ocular hypertension rats. Int J Ophthalmol. 4:40–43. 2011.PubMed/NCBI
10	Fu QL, Wu W, Wang H, Li X, Lee VW and So KF: Up-regulated endogenous erythropoietin/erythropoietin receptor system and exogenous erythropoietin rescue retinal ganglion cells after chronic ocular hypertension. Cell Mol Neurobiol. 28:317–329. 2008. View Article : Google Scholar
11	Yanni SE, McCollum GW and Penn JS: Genetic deletion of COX-2 diminishes VEGF production in mouse retinal Müller cells. Exp Eye Res. 91:34–41. 2010. View Article : Google Scholar : PubMed/NCBI
12	Lukiw WJ, Ottlecz A, Lambrou G, et al: Coordinate activation of HIF-1 and NF-κB DNA binding and COX-2 and VEGF expression in retinal cells by hypoxia. Invest Ophthalmol Vis Sci. 44:4163–4170. 2003. View Article : Google Scholar : PubMed/NCBI
13	Soengas MS, Alarcón RM, Yoshida H, Giaccia H, Hakem R, Mak TW and Lowe SW: Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. Science. 284:156–159. 1999. View Article : Google Scholar : PubMed/NCBI
14	Nishiyama J, Yi X, Venkatachalam M and Dong Z: cDNA cloning and promoter analysis of rat caspase-9. Biochem J. 360:49–56. 2001. View Article : Google Scholar : PubMed/NCBI
15	Hänninen VA, Pantcheva MB, Freeman EE, Poulin NR and Grosskreutz CL: Activation of caspase 9 in a rat model of experimental glaucoma. Curr Eye Res. 25:389–395. 2002. View Article : Google Scholar
16	Goldblum D and Mittag T: Prospects for relevant glaucoma models with retinal ganglion cell damage in the rodent eye. Vision Res. 42:471–478. 2002. View Article : Google Scholar : PubMed/NCBI
17	Quigley HA and Broman AT: The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 90:262–267. 2006. View Article : Google Scholar : PubMed/NCBI
18	Laquis S, Chaudhary P and Sharma SC: The patterns of retinal ganglion cell death in hypertensive eyes. Brain Res. 784:100–104. 1998. View Article : Google Scholar : PubMed/NCBI
19	Ahmed FA, Chaudhary P and Sharma SC: Effects of increased intraocular pressure on rat retinal ganglion cells. Int J Dev Neurosci. 19:209–218. 2001. View Article : Google Scholar : PubMed/NCBI
20	Huang SP, Wu MS, Shun CT, et al: Cyclooxygenase-2 increases hypoxia-inducible factor-1 and vascular endothelial growth factor to promote angiogenesis in gastric carcinoma. J Biomed Sci. 12:229–241. 2005. View Article : Google Scholar : PubMed/NCBI
21	Wang D and Dubois RN: The role of COX-2 in intestinal inflammation and colorectal cancer. Oncogene. 29:781–788. 2010. View Article : Google Scholar
22	Kaidi A, Qualtrough D, Williams AC and Paraskeva C: Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor (HIF)-1 promotes colorectal tumor cell survival and enhances HIF-1 transcriptional activity during hypoxia. Cancer Res. 66:6683–6691. 2006. View Article : Google Scholar : PubMed/NCBI
23	Savagian CA, Dubielzig RR and Nork TM: Comparison of the distribution of glial fibrillary acidic protein, heat shock protein 60, and hypoxia-inducible factor-1α in retinas from glaucomatous and normal canine eyes. Am J Vet Res. 69:265–272. 2008. View Article : Google Scholar : PubMed/NCBI
24	Chang ZY, Yeh MK, Chiang CH, Chen YH and Lu DW: Erythropoietin protects adult retinal ganglion cells against NMDA-, trophic factor withdrawal-, and TNF-α-induced damage. PLoS One. 8:e552912013. View Article : Google Scholar
25	Zhong L, Bradley J, Schubert W, et al: Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice. Invest Ophthalmol Vis Sci. 48:1212–1218. 2007. View Article : Google Scholar : PubMed/NCBI